← Back to Search

Routine Health Status Assessment for Heart Failure

N/A

Waitlist Available

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from date of randomization to study completion (up to 12 months)

Awards & highlights

Study Summary

This trial is testing whether routine assessment of patient-reported health status using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) impacts clinical processes of care among adult outpatients with heart failure. The primary objective is to evaluate clinician inertia by measuring the clinician action rating (CAR). Secondary outcomes include individual components of the composite outcome, therapy rates, resource utilization, and patient experience.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from date of randomization to study completion (up to 12 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from date of randomization to study completion (up to 12 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of randomization to study completion (up to 12 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinician action rating

Secondary outcome measures

Cardiology Clinic Visits

Diagnostic Testing

Diagnostic Tests

+15 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Health Status AssessmentExperimental Treatment1 Intervention

Completion of a patient-reported health status assessment preceding each clinic visit. The health status assessment consists of the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) along with additional select questions. The results of the assessment will be available to clinicians in the electronic health record.

Group II: Usual CareActive Control1 Intervention

Patients will not complete a patient-reported health status measures.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,390 Previous Clinical Trials

17,337,727 Total Patients Enrolled

18 Trials studying Heart Failure

53,358 Patients Enrolled for Heart Failure

Media Library

Routine Health Status Assessment Clinical Trial Eligibility Overview. Trial Name: NCT05564572 — N/A

Heart Failure Research Study Groups: Usual Care, Health Status Assessment

Heart Failure Clinical Trial 2023: Routine Health Status Assessment Highlights & Side Effects. Trial Name: NCT05564572 — N/A

Routine Health Status Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05564572 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment for this experiment commenced?

"Clinicaltrials.gov does not list this trial as actively recruiting patients, with the initial posting of September 7th 2022 and most recent update occurring on September 29th 2022. Despite this, there are plenty other trials that remain open to participants at present - 701 in fact."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology

Alexander Sandhu 2022. "Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05564572.